Incannex Healthcare has announced it has executed a license agreement with Monash University to develop a novel treatment that combines Virtual Reality and psychedelics. This marks the initiation of a second clinical psychedelic therapy program.
Category Press Release
Published in Yahoo Finance
Companies Featured
Incannex HealthcareIncannex Healthcare is a clinical-stage cannabinoid and psychedelic medicine developer.
Monash University
The Clinical Psychedelic Lab, established in 2020, within the Dept Psychiatry at Monash University is the first of its kind in Australia, leading the development and implementation of psychedelic therapies. The lab has played a central role in establishing the field of clinical psychedelic research in Australia.